Active, Not Recruiting
Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
NCT02992522
- Conditions
- B-Cell, B-Cell Lymphoma, Unspecified, Burkitt Lymphoma, +30 more
- Locations
-
- Emory University Atlanta, Georgia, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States